7th ICHNO Programme Book

7 TH ICHNO International Congress on innovative approaches in HEAD & NECK ONCOLOGY 14-16 March 2019 Barcelona, Spain

PROGRAMME BOOK AND EXHIBITION GUIDE

Download the ESTRO App: You will find the 7 TH ICHNO programme, speakers, exhibition and so much more

Follow our hashtag #ICHNO 7 and tune in for the latest updates!

Network: 7th_ICHNO Password: ichno2019

Pass by the ESTRO booth #10 in the exhibition hall!

WWW.ESTRO.ORG #ICHNO 7

TABLE OF CONTENTS

GENERAL INFORMATION

5

Introduction | 6 Scientific and advisory committees | 8 Acknowledgement | 9 Accreditation | 10

General information | 11 Programme overview | 13

SCIENTIFIC PROGRAMME Thursday 14 March 2019 | 16 Friday 15 March 2019 | 20 Saturday 16 March 2019 | 23

15

POSTERS

26

EXHIBITION

47

Floorplan | 48 Company details | 49 Acknowledgement to the industry | 51

SATELLITE SYMPOSIA Thursday 14 March 2019 | 54 Friday 15 March 2019 | 55

53

26-30 April 2019 Milan, Italy

Targeting optimal care, together

Targeting optimal care, together

#ESTRO 38 WWW.ESTRO.ORG

GENERAL INFORMATION

5

INTRODUCTION

A LETTER OF WELCOME FROM THE CONFERENCE CHAIRPERSONS

The European SocieTy for Radiotherapy and Oncology (ESTRO), the European Head and Neck Society (EHNS) and the European Society of Medical Oncology (ESMO) have the pleasure of welcoming you at the 7th edition of the International Congress on Innovative Approaches in Head and Neck Oncology (ICHNO) taking place in Barcelona, Spain, from 14 to 16 March 2019. This biennial congress will once again provide a unique platform for the dissemination of the most relevant and cutting-edge science and innovation in the field of head and neck oncology. This congress has been shaping up to be a major international event in promoting multidisciplinarity in head and neck oncology. With major emphasis on multidisciplinarity and innovation, this meeting will specifically cover the main following topics: • New insights in the epidemiology and prevention of head and neck cancer • Oncogenesis, HPV related cancers, immunology and vaccination • Updated results of practice changing randomised trials • Multidisciplinary management of head and neck cancers • Molecular targeted therapies and molecular imaging • Novel radiation and surgical treatments • Towards individualised management of head and neck cancer • Robotic and minimally invasive surgery • Reconstructive and salvage surgery • Elderly patients, comorbidities and their impact on management • New insight in systemic treatments of head and neck cancers • Thyroid, nasopharynx cancers and rare head and neck cancers • Quality of life, supportive care and management of treatment side effects The format of the meeting will feature prestigious invited ‘state of the art lectures’; lectures on the latest innovative approaches; proffered papers and poster presentations of new data in the field of head and neck oncology. The programme will be enriched by a debate and an Interactive tumour board session where the audience will have the possibility to participate and share their input via an electronic voting system. Ample time has been foreseen for discussions to allow in-depth interaction among the various disciplines and the participants.

GENERAL INFORMATION | PROGRAMME & EXHIBITION GUIDE

6

To stimulate multidisciplinary interactions among the various specialists, all the lectures, debates, tumour boards and proferred papers will be given in the same congress room. We hope that the mix of a rich and challenging scientific programme coupled with the enticing atmosphere of the city of Barcelona will make your attendance worthwhile.

Chairpersons of the 7th ICHNO conference

Jean-Pascal Machiels ESMO

Hans Langendijk ESTRO

René Leemans EHNS

PROGRAMME & EXHIBITION GUIDE | GENERAL INFORMATION

7

SCIENTIFIC AND ADVISORY COMMITTEES

SCIENTIFIC COMMITTEE H. Langendijk (NL), Chair of the congress, representing ESTRO R. Leemans (NL), Chair of the congress, representing EHNS J.-P. Machiels (BE), Chair of the congress, representing ESMO P. Blanchard (FR), Chair of the Advisory Committee for Radiation Oncology L. Licitra (IT), Chair of the Advisory Committee for Medical Oncology P. Nicolai (IT), Chair of the Advisory Committee for Surgery R. Brakenhoff (NL), Chair of the Advisory Committee for Head and Neck Cancer Related Sciences

ADVISORY COMMITTEE FOR MEDICAL ONCOLOGY L. Licitra (IT), Chair A. Argiris (GR) I. Brana (ES)

A. Chan (HK) S. Faivre (FR) U. Keilholz (DE) A. Kong (UK) L. Locati (IT)

ADVISORY COMMITTEE FOR SURGERY P. Nicolai (IT), Chair R. de Bree (NL) A. Dietz (DE) W. Golusinski (PL)

A. Mäkitie (FI) S. Parmar (UK)

M. Quer (ES) R. Simo (UK) S. Stoeckli (CH) V. Vander Poorten (BE)

ADVISORY COMMITTEE FOR RADIATION ONCOLOGY P. Blanchard (FR), Chair

ADVISORY COMMITTEE FOR HEAD AND NECK CANCER

P. Bonomo (IT) J. Eriksen (DK) J. Giralt (ES) V. Grégoire (BE) F. Herrerra (CH) A. Laprie (FR) S. Nuyts (BE)

RELATED SCIENCES R. Brakenhoff (NL) , Chair R. Ferris (US) J. Hess (DE) K. Hunter (UK) H. Pappot (DK) M. Robinson (UK) S. Singer (DE) I. Tinhofer-Keilholz (DE) R. van de Ven (NL)

M. Sen (UK) D. Zips (DE)

GENERAL INFORMATION | PROGRAMME & EXHIBITION GUIDE

8

ACKNOWLEDGEMENTS

ESTRO, the European SocieTy for Radiotherapy and Oncology, EHNS, the European Head and Neck Society, And ESMO, the European Society for Medical Oncology,

wish to thank the Scientific Committee Chairs, Hans Langendijk, C. René Leemans and Jean-Pascal Machiels for having accepted the responsibility to develop the scientific programme of this conference. A special thank you to the members of the advisory committees for having supported the development of the programme.

PROGRAMME & EXHIBITION GUIDE | GENERAL INFORMATION

9

ACCREDITATION

“The 7th International Congress on Innovative Approaches in Head and Neck Oncology (ICHNO), Barcelona, Spain, 14/03/2019-16/03/2019 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 9 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.” “Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits TM . Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/ earn-credit-participation-international-activities. “Live educational activities, occurring outside of Canada, recognised by the UEMS- EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.”

7th ICHNO Conference is accredited with 12 ESMO MORA Category 1 Points.

GENERAL INFORMATION | PROGRAMME & EXHIBITION GUIDE

10

GENERAL INFORMATION

LUNCHEONS AND REFRESHMENTS The registration fee for the conference includes lunches and coffee breaks served at the exhibition area.

VENUE Fira Barcelona Avda. Reina Maria Cristina 8004 Barcelona Spain

REGISTRATION: OPENING HOURS Wednesday 13 March: 16:00-18:00 Thursday 14 March: 7:30-18:00

ACCOMMODATION Hotel bookings can be done online through the 7th ICHNO webpage. The official housing agent for the conference will be Kuoni Congress: ichno2019@ ch.kuoni.com.

Friday 15 March: 8:00-17:00 Saturday 16 March: 7:30-12:00

WELCOME NETWORKING All participants and company delegates are invited to the Welcome Networking on Thursday March 14 at 17.45 taking place in the exhibition area.

CURRENCY The currency in Spain is the EURO.

OFFICIAL LANGUAGE The official language of the meeting is English. No simultaneous translation will be provided. POSTERS The poster area will be in the conference centre. Posters may be viewed at any time during the conference hours. EXHIBITION An exhibition featuring equipment and pharmaceutical companies as well as medical publishers will be held in the exhibition area. The exhibition will open on Thursday March 14. Entrance is free for all registered participants.

TRAVEL INFORMATION How to reach Barcelona from the airport:

TAXI El Prat International Airport is

approximately nine miles (14 kilometres) south- west of the centre of Barcelona and taxis are available at the airport 24 hours a day. It takes roughly between twenty and forty minutes into the centre of town and the fare is about €30-45; tariffs can vary according to the time of day and supplements (e.g. luggage). The fares should be displayed in the taxi and the amount payable should be indicated on the meter.

AEROBUS AEROBÚS is the official shuttle bus

PROGRAMME & EXHIBITION GUIDE | GENERAL INFORMATION

11

service that connects the airport BCN- El Prat and the centre of Barcelona every 5 minutes, every day of the year, in approximately 35 minutes. This is the fastest way to reach the city centre with public transport. Passengers are able to travel between any of the two airport terminals (T1 or T2) and the centre of Barcelona (Pl. Catalunya) in only three stops in a fast, comfortable and economical way. Along the route there are stops at the most important points of the city: Pl. Catalunya, Sepúlveda-Urgell, Pl. Espanya, Gran Vía- Urgell, and Pl. Universitat. Free Wifi and USB chargers on board. Price single ticket: €5,90. METRO The subway or metro now connects both terminals of the airport with Barcelona underground network. The line is called L9 Sud. There are stops at T1 (inside the building) and T2 (outside the building, next to train station): in both cases follow the signs. TRAIN You can catch the train from Clot, Passeigde Gracia, or Barcelona Sants (Sants Estacio). The name of the stop for the airport is Aeropuerto. If travelling from the airport to the city centre you can get off at Barcelona Sants, Pas- seig de Gracia or Clot which are serviced by metro stops. From these you can change for the Barcelona metro underground system to go to your final destination.

GENERAL INFORMATION | PROGRAMME & EXHIBITION GUIDE

12

PROGRAMME OVERVIEW

Thursday 14 March 2019 09:15-09:30 Opening remarks 09:30-10:00

Keynote lecture 1: New insights into the molecular landscape of H&N cancer 10:00-10:30 Keynote lecture 2: New insights into the immune landscape of H&N cancer 10:30-11:00 Coffee break 11:00-12:00 Debate 1: This house believes that radiomics will not change clinical practice 12:00-13:00 Proffered papers 1 13:00-14:30 Lunch and Satellite symposium 14:30-15:30 L ate breaking news 15:30-16:00 Keynote lecture 3 : TNM8: How has the dust settled one year later? 16:00-16:30 Coffee break 16:30-17:45 Symposium 1: Immuno-oncology 17:45-19:00 Welcome networking Friday 15 March 2019 09:00-09:30 Keynote lecture 4: SNUC: a sustainable concept? 09:30-10:00 Keynote lecture 5: Pushing the limits in H&N robotic surgery 10:00-10:30 Coffee break 10:30-11:30 Proffered papers 2 11:30-12:45 Symposium 2: New developments in radiation therapy 12:45-14:15 Lunch and Satellite symposium 14:15-15:15 Interactive tumor board session: Oropharynx 15:15-15:45 Poster discussion 15:45-16:15 Coffee break 16:15-17:30 Symposium 3: New techniques in surgery Saturday 16 March 2019 08:15-08:45 Keynote lecture 6: Integration of imaging and radiotherapy innovation 08:45-10:00 Symposium 4: How to improve survivorship? 10:00-10:30 Coffee break 10:30-11:30 Proffered papers 3 11:30-12:30 Debate 2: This house believes that immunotherapy is going to replace chemotherapy 12:30-12:45 Concluding remarks / poster award / oral communication award

PROGRAMME & EXHIBITION GUIDE | GENERAL INFORMATION

13

ESTRO SCHOOL OF RADIOTHERAPY AND ONCOLOGY WWW.ESTRO.ORG

2019

POSTGRADUATE COURSES IN EUROPE

Evidence Based Radiation Oncology 24-29 June 2019 | Montpellier, France Clinical Practice and Implementation of Image-Guided Stereotactic Body Radiotherapy 1-5 September 2019 | Florence, Italy Physics for Modern Radiotherapy A joint course for clinicians and physicists 8-12 September 2019 | Riga, Latvia Advanced Treatment Planning 22-26 September 2019 | Budapest, Hungary Imaging for Physicists 29 September - 3 October 2019 | Manchester, UK Image-GuidedRadiotherapyandChemo- therapy inGynaecologicalCancer:Focus onMRIBasedAdaptiveBrachytherapy 12-16 October 2019 | Cluj, Romania Comprehensive Quality Management in Radiotherapy – Quality Assessment and Improvement 13-16 October 2019 | Dublin, Ireland Best Practice in Radiation Oncology Train the RTT (Radiation Therapists) Trainers - Part II 19-20 October 2019 | Brussels, Belgium Multidisciplinary Management of Breast Cancer 27-30 October 2019 | Budapest, Hungary Research Course in Radiation Oncology How to develop research/validation programmes when implementing new technology? Edition 1: MRI Linac 3-6 November 2019 | Madrid, Spain Research Course in Radiotherapy Physics 3-6 November 2019 | Madrid, Spain ESTRO/ESOR Multidisciplinary Approach of Cancer Imaging 4-5November2019 |Amsterdam,TheNetherlands Multidisciplinary Management of Non-Melanoma Skin Cancer 7-9 November 2019 | Brussels, Belgium 14-16 October 2019 | Vienna, Austria Positioning and Immobilisation for Radiation Therapy

Palliative Care and Radiotherapy A course on prognosis, symptom control, re-irradiation, oligometastases 26-28 November 2019 | Brussels, Belgium Paediatric Radiotherapy 1-3 December 2019 | Utrecht, The Netherlands Multidisciplinary Management of Brain Tumours 1-3 December 2019 | Brussels, Belgium 3D Radiotherapy with a Special Empha- sis on Implementation of MRI/CT Based Brachytherapy in Cervical Cancer 14-17 March 2019 | Rishikesh, India Palliative care and Radiotherapy A course on prognosis, symptom control, re-irradiation, oligometastases 26-28 March 2019 | Manila, Philippines Combined Drug-radiation Treatment: Biological Basis, Current Applications and Perspectives 7-9 June 2019 | Seoul, South Korea Multidisciplinary Management of Head and Neck Oncology 28-31 October 2019 | Mexico City, Mexico Advanced Technologies 3-6 November 2019 | Shenzhen, China Advanced Technologies India | Date and venue to be announced

Image-Guided Radiotherapy in Clinical Practice 17-21 February 2019 | Porto, Portugal Basic Clinical Radiobiology 3-7 March 2019 | Brussels, Belgium Comprehensive and Practical Brachytherapy 3-7 March 2019 | Athens, Greece Particle Therapy 18-22 March 2019 | Groningen, The Netherlands Lower GI – Technical and Clinical Challenges for Radiation Oncologists 20-22 March 2019 | Amsterdam, The Netherlands Upper GI – Technical and Clinical Challenges for Radiation Oncologists 23-26 March 2019 | Amsterdam, The Netherlands Foundations of Leadership in Radiation Oncology 26 April 2019 | Milan, Italy ESTRO/ESMIT course on Molecular Imaging and Radiation Oncology 6-9 May 2019 | Florence, Italy Advanced Skills in Modern Radiotherapy 19-23 May 2019 | Brussels, Belgium Multidisciplinary Management of Prostate Cancer 19-23 May 2019 | Pisa, Italy Dose Modelling and Verification for External Beam Radiotherapy 19-23 May 2019 | Lisbon, Portugal Target Volume Determination – From Imaging to Margins 2-5 June 2019 | Athens, Greece IMRT and Other Highly Conformal Techniques in Practice 2-6 June 2019 | Budapest, Hungary Brachytherapy for Prostate Cancer 13-15 June 2019 | Prague, Czech Republic

POSTGRADUATE COURSES OUTSIDE EUROPE

PRE-MEETING COURSES 8 Pre-Meeting Courses at ESTRO 38 26 April 2019 | Milan, Italy

NEW

UNDERGRADUATE COURSES Medical Science Summer School Oncology for Medical Students 15 -27 July 2019 | Vienna, Austria ESO-ESSO-ESTROMultidisciplinary Course in Oncology for Medical Students 26 August - 6 September 2019 | Turin, Italy

MULTIMODALCANCERTREATMENT

RADIOTHERAPYTREATMENTPLANNINGANDDELIVERY

BIOLOGY

IMAGING

RESEARCH

BESTPRACTICE

SCIENTIFIC PROGRAMME

15

THURSDAY 14 MARCH 2019

CONFERENCE REMARKS Opening remarks 09:15 - 09:30 | Auditorium

09:15 Chair: H. Langendijk (The Netherlands) 09:20 Chair: C.R. Leemans (The Netherlands) 09:25 Chair: J.P. Machiels (Belgium)

KEYNOTE LECTURE 1 New insights into the molecular landscape of Head and Neck cancer 09:30 - 10:00 | Auditorium Chair: H. Langendijk (The Netherlands) Chair: C.R. Leemans (The Netherlands) Chair: J.P. Machiels (Belgium) 09:30 New insights into the molecular landscape of Head and Neck cancer Speaker: R. Brakenhoff (The Netherlands)

SP-001

KEYNOTE LECTURE 2 New insights into the immune landscape of Head and Neck cancer 10:00 - 10:30 | Auditorium

Chair: H. Langendijk (The Netherlands) Chair: C.R. Leemans (The Netherlands) Chair: J.P. Machiels (Belgium) 10:00 Immune landscape in Head and Neck cancer Speaker: S. Brandau (Germany)

SP-002

SCIENTIFIC PROGRAMME | PROGRAMME & EXHIBITION GUIDE

16

DEBATE 1 This house believes that radiomics will not change clinical practice

11:00 - 12:00 | Auditorium Chair: A. Mäkitie (Finland) Chair: J.G. Eriksen (Denmark) 11:00 For the motion

Speaker: V. Grégoire (France)

SP-003

11:20 Against the motion

Speaker: P. Lambin (The Netherlands)

SP-004

11:40 For the motion rebuttal V. Grégoire (France) 11:45 Against the motion rebuttal P. Lambin (The Netherlands) 11:50 Discussion

PROFFERED PAPERS Proffered paper 1

12:00 - 13:00 | Auditorium Chair: S. Nuyts (Belgium) Chair: M. Sen (United Kingdom) 12:00 Preoperative vs. postoperative radiotherapy in treatment of oral cavity cancer – The ARTSCAN 2 study C. Kristin (Sweden), Z. Björn, N. Per, K. Elisabeth, B. Eva, S. Karin, R. Johan, K. Stefan, G. Maria, S. Johanna, J. Wennerberg 12:10 Individualized prophylactic irradiation based on sentinel lymph node(s) identification in cN0 HNSCC E. Longton (Belgium), G. Lawson, B. Bihin, S. Deheneffe, I. Mathieu, F. Hanin, T. Vander Borght, M. Laloux, J. Daisne

OC-005

OC-006

PROGRAMME & EXHIBITION GUIDE | SCIENTIFIC PROGRAMME

17

12:20 Radiologic extranodal extension portends worse outcome in TNM-8 cT1-T2N1 HPV+ oropharyngeal cancer S.H.S. Huang (Canada), E. Yu, A. Billfalk-Kelly, J. Su, J. Waldron, E. Bartlett, A. Bayley, S. Bratman, J. Cho, M. Giuliani, A. Hope, A. Hosni, J. Kim, J. Ringash, A. Hansen, J. De Almeida, L. Tong, W. Xu, B. O’Sullivan 12:30 Fast tumor regression detected by weekly MRI allows for adaptive (chemo) radiation for Head and Neck cancer 12:40 Carbon-ion reirradiation for recurrent head-and-neck cancer: A single-institutional experience T. Held (Germany), P. Windisch, S. Akbaba, K. Lang, D. Bernhardt, P. Plinkert, K. Freier, S. Kargus, S. Rieken, K. Herfarth, J. Debus, S. Adeberg 12:50 Local recurrence of nasopharyngeal carcinomas – outcomes after reirradiation A. Ruffier-Loubière (France), Y.G. Tao, F. NGuyen, A. Moya-Plana, C. Even, C. Berthold, O. Casiraghi, S. Temam, P. Blanchard C. Terhaard (The Netherlands), B. Peltenburg, R. De Bree, N. Raaijmakers, J.W. Dankbaar, F. Pameijer, M. Philippens

OC-007

OC-008

OC-009

OC-010

LATE BREAKING NEWS Late breaking news 14:30 - 15:30 | Auditorium Chair: R. Van de Ven (The Netherlands) Chair: J. Bourhis (Switzerland) 14:30 New insights from the De-ESCALate HPV trial

H. Mehanna (United Kingdom), M. Robinson, A. Hartley, A. Kong, B. Foran, T. Fulton-Lieuw, M. Dalby, P. Mistry, M. Sen, L. O’Toole, J. Dunn

OC-011

14:45 First-line pembrolizumab alone or with chemotherapy in recurrent/metastatic (R/M) HNSCC: KEYNOTE-048 Speaker: B. Burtness (USA)

SP-012

Discussant: S. Faivre (France)

15:10

SCIENTIFIC PROGRAMME | PROGRAMME & EXHIBITION GUIDE

18

KEYNOTE LECTURE 3 TNM8: How has the dust settled one year later? 15:30 - 16:00 | Auditorium Chair: H. Langendijk (The Netherlands) Chair: C.R. Leemans (The Netherlands) Chair: J.P. Machiels (Belgium) 15:30 TNM8: How has the dust settled one year later?

Speaker: B. O’Sullivan (Canada), R. Wu, S.H. Huang, W. Xu, V. Gregoire, S. Patel, J. Brierley, W. Lydiatt

SP-013

SYMPOSIUM 1 Immuno-oncology 16:30 - 17:45 | Auditorium Chair: I. Brana (Spain) Chair: W. Golusinski (Poland ) 16:30 Immuno-scoring

Speaker: J. Galon (France)

SP-014

16:55 Current status of immunotherapy in Head and Neck cancer Speaker: L. Licitra (Italy) 17:20 Integration of immunotherapy with radiotherapy in Head and Neck cancer Speaker: P. Huber (Germany)

SP-015

SP-016

PROGRAMME & EXHIBITION GUIDE | SCIENTIFIC PROGRAMME

19

FRIDAY 15 MARCH 2019

KEYNOTE LECTURE 4 SNUC: a sustainable concept? 09:00 - 09:30 | Auditorium Chair: R.de Bree (The Netherlands) Chair: M. Quer (Spain) 09:00 SNUC: a sustainable concept? Speaker: A. Franchi (Italy)

SP-017

KEYNOTE LECTURE 5 Pushing the limits in Head and Neck robotic surgery 09:30 - 10:00 | Auditorium Chair: J. Giralt (Spain) Chair: V. Vander Poorten (Belgium) 09:30 Pushing the limits in Head and Neck robotic surgery Speaker: C. Simon (Switzerland)

SP-018

PROFFERED PAPERS Proffered papers 2 10:30 - 11:30 | Auditorium Chair: P. Nicolai (Italy) Chair: W. Golusinski (Poland)

What is the optimal cut-off of depth of invasion for elective neck dissection in oral cavity cancer? Abstract withdrawn Sentinel lymph node biopsy for early stage oral cancer: experience of 3 Dutch Head and Neck centers I. Den Toom (The Netherlands), K. Boeve, R. Van Es, B. De Keizer, S. Van Weert, S. Willems, M. Witjes, E. Bloemena, R. Leemans, R. De Bree

OC-019

10:30

OC-020

SCIENTIFIC PROGRAMME | PROGRAMME & EXHIBITION GUIDE

20

10:40 Transoral Laser Microsurgery for T1a glottic cancer - DAHANCA 27 N. Lyhne (Denmark), K. Hald, T. Kjærgaard, C. Godballe, J. Tvedskov, B. Ulhøj, J. Overgaard Unexpected drainage patterns and high accuracy of SLNB in OSCC after previous neck treatment K. Boeve (The Netherlands), I.J. Den Toom, S. Van Weert, E. Bloemena, A.H. Brouwers, O.S. Hoekstra, B. De Keizer, B. Van der Vegt, S. Willems, C.R. Leemans, M.J.H. Witjes, R. De Bree 11:00 Real life application of the PET-Neck protocol for post radiotherapy surveillance in advanced HNSCC S. Zhou (United Kingdom), R. Rulach, F. Hendry, D. Stobo, M.F. Dempsey, D. Grose, C. Lamb, A. James, S. Schipani, M. Rizwannullah, C. Wilson, C. Paterson 10:50

OC-021

OC-022

OC-023

11:10

12 week PET-CTs have a low PPV for nodal residual disease in HPV positive oropharygeal cancers R. Rulach (United Kingdom), S. Zhou, F. Hendry, D. Stobo, M.F. Dempsey, D. Grose, C. Lamb, A. James, S. Schipani, M. Rizwanullah, C. Wilson, C. Paterson

OC-024

SYMPOSIUM 2 New developments in radiation therapy

11:30 - 12:45 | Auditorium Chair: S. Nuyts (Belgium) Chair: A. Dietz (Germany) 11:30

The fourth major salivary gland and its clinical implications Speaker: W. Vogel (The Netherlands) Modern IMRT planning, how high can we push the bar? Speaker: C. Rønn Hansen (Denmark) New developments in proton therapy in Head and Neck cancer Speaker: D. Thomson (United Kingdom)

SP-025

11:50

SP-026

12:10

SP-027

PROGRAMME & EXHIBITION GUIDE | SCIENTIFIC PROGRAMME

21

12:30

Early response evaluation in radiation therapy driven larynx organ preservation Speaker: A. Dietz (Germany)

SP-028

INTERACTIVE TUMOUR BOARD SESSION Oropharynx

14:15 - 15:15 | Auditorium Chair: A. Argiris (Greece)

Panellist: F. Pameijer (The Netherlands) Panellist: C. Von Buchwald (Denmark) Panellist: A. Castro (Portugal) Panellist: W. Budach (Germany)

POSTER DISCUSSION Poster discussion 15:15 - 15:45 | Auditorium Chair: A. Psyrri (Greece) Chair: A. Laprie (France) 15:15

Phase II trial:melatonin oral gel for prevention of mucositis in oropharynx and oral cavity tumors A. Lozano Borbalas (Spain), J. Marruecos, J. Rubio-Casadevall, N. Farre, A. Lopez-Pousa, J. Gomez-Millan, M.D. Toledo, R. Morera, L. Glaria, I. Planas, R. Mesia, M. Lanzuela, J. Giralt, L. Cascallar, G. Vazquez Masedo, V. Valenti, J. Ortiz, P. Grima, C. Tarrago, R. Bosser Does multiparametric imaging with FDG-PET/MRI capture intratumor heterogeneity in histopathology? J. Rasmussen (Denmark), A. Olin, G. Lelkaitis, A.E. Hansen, H.H. Johannesen, A. Kjær, I.R. Vogelius, L. Specht, I. Wessel, C.V. Buchwald, B.M. Fishcer

PD-029

15:18

PD-030

SCIENTIFIC PROGRAMME | PROGRAMME & EXHIBITION GUIDE

22

15:21

CT-based Radiomics Predicting HPV Status in Head and Neck Squamous Cell Carcinoma Z. Shi (The Netherlands), C. Zhang, M. Welch, P. Petros, L. Wee, A. Dekker Incidence and management of laryngeal squamous cell carcinoma in the Nordic countries A. Haapaniemi (Denmark), H. Haugen, N.M. Lyhne, A. Bratland, J. Subhash, J. Wennerberg, J. Brandstorp-Boesen, A. Mäkitie, J. Overgaard

PD-031

15:24

PD-032

15:27

Discussant: P. Blanchard (France)

SYMPOSIUM 3 New techniques in surgery 16:15 - 17:30 | Auditorium Chair: S. Stoeckli (Switzerland) Chair: J. Vermorken (Belgium) 16:15 Bio-endoscopy

Speaker: G. Peretti (Italy)

SP-033

16:40

3 Dimension Reconstruction in the Head and Neck Speaker: S. Parmar (United Kingdom)

SP-034

17:05

New developments in sentinel node biopsy Speaker: R. De Bree (The Netherlands)

SP-035

PROGRAMME & EXHIBITION GUIDE | SCIENTIFIC PROGRAMME

23

SATURDAY 16 MARCH 2019

KEYNOTE LECTURE 6 Integration of imaging and radiotherapy innovation: Head and Neck radiotherapy applications 08:15 - 08:45 | Auditorium

Chair: H. Langendijk (The Netherlands) Chair: C.R. Leemans (The Netherlands) Chair: J. P. Machiels (Belgium) 08:15 Integration of imaging and radiotherapy innovation: Head and neck radiotherapy applications. Speaker: C. Fuller (USA) SYMPOSIUM 4 How to improve survivorship? 08:45 - 10:00 | Auditorium Chair: C. A. Kristensen (Denmark) Chair: P. Bossi (Italy) 08:45 How to make use of the AHNS survivorship guidelines? Speaker: A. Sacco (USA) 09:05 Self management and eHealth to facilitate supportive care in Head and Neck cancer patients Speaker: I. Verdonck-de Leeuw (The Netherlands) 09:25 Discussion: How to improve survivorship: patient’s point of view Speaker: A. Steinbacher (Germany)

SP-036

SP-037

SP-038

SP-039

Discussion

09:35

SCIENTIFIC PROGRAMME | PROGRAMME & EXHIBITION GUIDE

24

PROFFERED PAPERS Proffered papers 3 10:30 - 11:30 | Auditorium Chair: S. Oosting (The Netherlands) Chair: L.D. Locati (Italy) 10:30 Nomogram for cumulative cisplatin dose for LAHNC receiving tri-weekly high-dose cisplatin CCRT T. Wang (Taiwan), M. Lien, C. Hua, H. Ching-Yun, T. Ming-Hsui 10:40 DAHANCA 28a: Phase I/II study of acc. hyperfractionated RT, cisplatin and nimorazole in p16- LAHNSCC M. Saksø (Denmark), K. Jensen, M. Andersen, J.G. Eriksen, J. Overgaard 10:50 Genomic characterization of oral premalignant lesions to identify high-risk molecular clusters P. Bossi (Italy), F. Perrone, M.S. Serafini, G. Pruneri, C. Piazza, L. Licitra, L. De Cecco 11:00 HNSCC in elderly frail patients treated by hafnium oxide nanoparticles activated by IMRT C. Hoffmann (France), V. Calugaru, V. Moreno Garcia, X. Mirabel, B. Doger de Spéville, E. Calvo, T. Jouffroy, J. Rodrigez, A. Chilles-Wang, M. Yemi, M. Lesnik, N. Badois, X. Liem, S. Salas, N. Fakhri, S. Wong Hee Khanà, C. Le Tourneau 11:10 Are elderly HNSCC patients undertreated? An analysis of outcomes using the SEER-Medicare database. I. Suzuki (USA), K. Cullen, S. Bentzen, O. Goloubeva 11:20 Socioeconomic inequality in head and neck cancer survival – a population-based study from DAHANCA M.H. Olsen (Denmark), P. Lassen, C. Rotbøl, T.K. Kjær, E.A.W. Andersen, J. Overgaard, S.O. Dalton

OC-040

OC-041

OC-042

OC-043

OC-044

OC-045

PROGRAMME & EXHIBITION GUIDE | SCIENTIFIC PROGRAMME

25

DEBATE 2 This house believes that immunotherapy is going to replace chemotherapy 11:30 - 12:30 | Auditorium

Chair: J.P. Machiels (Belgium) Chair: P. Blanchard (France) 11:30 For the motion

Speaker: K. Harrington (United Kingdom)

SP-046

11:50 Against the motion

Speaker: S. Faivre (France)

SP-047

12:10 For the motion rebuttal

K. Harrington (United Kingdom)

12:15 Against the motion rebuttal S. Faivre (France) 12:20 Discussion

CONFERENCE REMARKS Concluding remarks / poster award / oral communication award 12:30 - 12:45 | Auditorium

Chair: H. Langendijk (The Netherlands) Chair: C.R. Leemans (The Netherlands) Chair: J.P. Machiels (Belgium)

SCIENTIFIC PROGRAMME | PROGRAMME & EXHIBITION GUIDE

26

POSTERS

27

POSTER Multidisciplinary management

Hypofractionated dose escalated VMAT: comparable efficacy and less toxicity than standard CCRT in HNC E. Saad (Egypt), E. Abdel Hadi, R. Hani Radwan, M. Abdulla Management SCC unknown primary with contemporary diagnostic and radiotherapy techniques C. Paterson (United Kingdom), R. Crosbie, P. McLoone, D. Grose, A. James, C. Lamb, M. Rizwanullah, S. Schipani, C. Wilson, F. Campbell, F. Easton, M. Thomson Sinonasal undifferentiated carcinoma (SNUC) - endoscopic resection, chemo-radiation in 10 cases A. Dreyer (South Africa) Surgery versus Radiotherapy in T1N0 glottic cancer: 10 year outcomes R. Pocinho (Portugal), E. Netto, L. Fonseca, S. Esteves, M. Labareda, A. Mota, M. Magalhães, F. Santos T3 Laryngeal SCC: a mono- institutional retrospective analysis of different therapeutic approaches A. Bacigalupo (Italy), L. Belgioia, E. Tornari, S. Vecchio, M. Filauro, F. Marchi, G. Peretti, R. Corvò A questionnaire-based survey on current management strategies for Head and Neck cancer in China C. Wu (China), L. Guang Adaptive radiotherapy in Head and Neck cancers; Which patient group needs to be prioritised? M. Figen (Turkey), D. Colpan Oksuz, E. Duman, R. Prestwich, K. Dyker, K. Cardale, V. Ramasamy, P. Murray, M. Sen Interfractional brachial plexus movement during radical radiotherapy in Head and Neck cancer A. Sarwar (United Kingdom), A. Thompson, S. English

PO-048

PO-049

PO-050

PO-051

PO-052

PO-053

PO-054

PO-055

POSTERS | PROGRAMME & EXHIBITION GUIDE

28

Management of the N3 neck after radical chemoradiation for Head and Neck cancer D. Gujral (United Kingdom), M. Ingle, C. Podesta, J. Virk, Z. Awad Predicting risk of Acute Kidney Injury in Head and Neck cancer patients receiving chemoradiotherapy S. Gaito (United Kingdom), V.R. Kota, A. Abravan, K. Garcez, L.W. Lee, A.J. Sykes, D. Thomson, K. Mais, A. McPartlin Cisplatin, Fluorouracil, Docetaxel in Head and Neck Carcinoma: real data of induction chemotherapy F. Ferreira Pereira (Portugal), L. Castro Oliveira, I. Azevedo, J. Dinis, C. Vieira Association of pretreatment nutritional status on outcome of radiotherapy in Head and Neck SCC M. Emarah (Egypt), N. El-Deeb, A.A. Belal, W. Arafat Outcomes from concomitant cetuximab with radiotherapy in HNSCC: A retrospective cohort study C. Paterson (United Kingdom), A. Morton, C. Lamb, C. Wilson, D. Grose, M. Rizwanullah, S. Schipani, F. Easton, F. Campbell, A. James, M. Philip, M. Thomson Evaluating time from surgery to RT in Head and Neck cancer patients: a retrospective review of practice C. Paterson (United Kingdom), P. McLoone, M. Thomson Intensity Modulated Radiotherapy (IMRT) for Ca Nasopharynx –A Retrospective Analysis C. Kainickal (India), F. N, R.R. Kumar, M. Rafi, L. Al, S. Bhasi, P. Geaorge, R. Kunnambath Induction chemotherapy followed by radiotherapy for organ preservation in Oropharyngeal Cancer G. Fanetti (Italy), C. Gobitti, E. Minatel, A. Revelant, M. Avanzo, G. Pirrone, J. Polesel, E. Vaccher, O. Schioppa, F. Martellotta, G. Giuseppe, V. Lupato, T. Baresic, C. Bampo, G. Vittorio, E. Borsatti, G. Sartor, G. Franchin

PO-056

PO-057

PO-058

PO-059

PO-060

PO-061

PO-062

PO-063

PROGRAMME & EXHIBITION GUIDE | POSTERS

29

Changes in target volumes and dosimetric impact during the IMRT treatment of NPC H. Daoud (Tunisia), M. Wafa, F. Leila, F. Nejla, S. Wicem, D. Jamel Do comorbidities affect survival in Head and Neck cancer treated with Cetuximab and Radiotherapy? G. Fanetti (Italy), C. Gobitti, E. Minatel, A. Revelant, A. Drigo, P. Chiovati, C. Cappelletto, S. Steffanini, G. Franchin Primary laryngectomy vs chemoradiotherapy in T3 laryngeal cancer: a comparison of treatment outcomes A. Owen (United Kingdom), L. Pope Should we consider the hippocampus when optimizing the IMRT of NPC? W. Mnejja, H. Daoud (Tunisia), L. Farhat, N. Fourati, W. Siala, J. Daoud Locoregional Relapse Impact on Survival for Resected Early Stage Oral Tongue Carcinoma M. Labareda (Portugal), E. Netto, J. Filipe, R. Pocinho, A. Mota, S. Esteves, I. Fonseca Efficacy of Neoadjuvant chemotherapy in locally advanced oral cancers- a randomized pilot study P. Shivanna (India), R. Pramanik, A. Sharma, R. Sahoo, S. Bhaskar, S. Thulkar, S.V.S. Deo Prognostic value of hyponatremia on metastatic or recurrent Head and Neck squamous cell carcinoma C. Melo Alvim Moreira (Portugal), P. Semedo, R. Paiva, S. Lobo Martins, H. Pais, A.L. Costa, L. Ribeiro, L. Costa Critical weight loss and feeding tube use in patients with HPV-positive oropharynx cancer Abstract withdrawn Differentiated dysplasia, an undervalued precursor of oral squamous cell carcinoma S. Koljenovic (The Netherlands), S. Dasgupta, P. Ewing-Graham, V. De Water, I. Ten Hove, R. Baatenburg de Jong, E. Wolvius, F. Van Kemenade, G. Puppels, V. Noordhoek Hegt

PO-064

PO-065

PO-066

PO-067

PO-068

PO-069

PO-070

PO-071

PO-072

POSTERS | PROGRAMME & EXHIBITION GUIDE

30

Outcomes and patterns of failure of oral squamous cell carcinomas treated post-operatively with IMRT R. Waldram (United Kingdom), A. Taylor, R. Prestwich, S. Whittam, L. Murray, B. Al-Qaisieh, K. Cardale, S. Ramasamy, P. Murray, K. Dyker, M. Sen Pharyngoesophageal stricture following laryngeal-hypopharyngeal cancer treatment-management outcome R. Sood (India), P. Vinodbhai Rathod, Y. Dokhe, K. Kamaleshkumar Jani, V. Sivakumar, D. Balasubramanian, S. Iyer, K. Thankappan, S. Sadasivan Disease- and treatment induced cachexia in locally advanced Head and Neck squamous cell carcinoma A. Hoeben (The Netherlands), R.I. Lalisang, A. Van Helvoort, L.W.J. Baijens, F.W.R. Wesseling, F. Hoebers, A.M.W.J. Schols Predictors of postoperative pneumonia in patient undergoing oral cancer resection and its management R. Sood (India), J. Paul, S. Rajan, S. Subramanian, D. Balasubramanian, S. Lyer Long-term outcome of IMRT with simultaneous integrated boost in nasopharyngeal carcinoma I. Linares (Spain), M. Taberna, J. Nogués, R. Mesía, D. Najjari, J. Mases, I. Guix, M. Plana, A. Lozano Radio-chemotherapy for Head and Neck cancer: retrospective comparison between weekly and three-weekly CDDP M. Gerardi (Italy), M. Buglione, D. Alterio, M. Maddalo, D. Greco, M. Augugliaro, A. Alghisi, M. Bonù, L. Costa, A. Ferrari, G. Marvaso, D. Tomasini, M. Cossu Rocca, R. Orecchia, S.M. Magrini, B.A. Jereczek-Fossa Up-front surgery and adjuvant RT of paranasal sinuses carcinoma: single center retrospective study M. Labareda (Portugal), E. Netto, S. Esteves, R. Pocinho, A. Mota, J. Fonseca, I. Antão, F. Santos, P. Montalvão, M. Magalhães Radiotherapy versus concurrent chemo radiotherapy in cancers of unknown primary of Head and Neck A. Bahl (India), A. Elangovan, A.S. Oinam, R. Kumar, B.R. Mittal, R. Verma, N. Panda, S. Ghoshal

PO-073

PO-074

PO-075

PO-076

PO-077

PO-078

PO-079

PO-080

PROGRAMME & EXHIBITION GUIDE | POSTERS

31

Multiple primary malignant neoplasms of Head and Neck Z. Fessi N. Fourati (Tunisia), W. Mnejja, W. Ben Kridis, I. Charfeddine, A. Khanfir, W. Siala, J. Daoud Helical Tomotheray in Head and Neck Cancer: Retrospective Single Institution Experience C. Gil Restrepo (Spain), A. Nieto Palacios, A.I. Rodríguez Gutiérrez, P. Soria Carreras, O. Alonso Rodríguez, S. García Repiso, C. Martín Rincón, L.A. Pérez Romasanta Analysis of received doses at organs of risk in SCCHN patients treated with postoperative VMAT-SIB I. Djan (Serbia), B. Petrovic, L. Rutonjski, B. Nikolin, R. Jović Quantification of the impact of radiologic imaging revision in Head and Neck cancer D. Alterio, L. Preda, S. Volpe (Italy), C. Giannitto, G. Riva, A.F.K. Pounou, M. Atac, G. Giuliano, A. Ferrari, G. Marvaso, S. Durante, S. Arculeo, I. Turturici, M. Cossu Rocca, M. Ansarin, M. Bellomi, B.A. Jereczek-Fossa, R. Orecchia Post-radiotherapy N3 nodal response in HPV positive SCC: a systematic review Z.Awad (United Kingdom), M. Ingle, C. Podesta, D. Gujral

PO-081

PO-082

PO-083

PO-084

PO-085

POSTERS | PROGRAMME & EXHIBITION GUIDE

32

POSTER Innovative treatments

Buparlisib (AN2025) as a potential treatment for anti-PD-1 non-responding tumor J. Wang (China), P. Chen, Z. Chen, T. Kaiyang Apatinib combined with oral chemotherapy in patients with recurrent/ metastatic Head and Neck cancer S. Dou (China), R. Li, L. Xie, Z. Wang, C. Zhang, L. Zhang, G. Zhu Assessment of acute toxicities in nasopharyngeal carcinoma with IMRT - A tale of two contours V. Pareek (India) Incidence of hypothyroidism following EBRT in Head and Neck malignancies with DVH predictors V. Pareek (India), R. Bhalavat, M. Chandra, C. Bakshi, S. Dutta The advantages of a pectoralis major myofascial flap in reconstruction of the oropharyngeal defects N. Trizna (Belarus), I. Belatserkouski, J. Kaliadzich Metronomic chemotherapy in borderline operable oral cavity squamous cell carcinoma - a pilot study B. Bansal (India), M. Sultania, S. Deo, N. Shukla, A. Sharma, R. Sahoo, S. Bhaskar Can Brachytherapy help reduce the dose to DARS in Head and Neck cancer? – A Clinical experience V. Pareek (India), R. Bhalavat, M. Chandra New combination of targeted therapies for thyroid cancer treatment L. Gheysen (Belgium), G. Attardo, F. Journe, S. Saussez Relocation of inadequate resection margins in the wound bed in oral cavity oncological surgery Abstract withdrawn

PO-086

PO-087

PO-088

PO-089

PO-090

PO-091

PO-092

PO-093

PO-094

PROGRAMME & EXHIBITION GUIDE | POSTERS

33

Objective intra-operative assessment of resection margins in Head and Neck cancer surgery Y. Aaboubout (The Netherlands), E.M.L. Barroso, C.G.F. Van Lanschot, T. Bakker Schut, I. Ten Hove, H. Mast, R. Smits, M. Van der Kamp, A. Sewnaik, J. Hardillo, C. Meeuwis, D. Monserez, S. Keereweer, V. Noordhoek Hegt, P. Caspers, R.J. Baatenburg de Jong, E. Wolvius, A. Bocharnikov, G.J. Puppels, S. Koljenović Follow up after intra-operative assessment of resection margins in oral cavity carcinoma surgery R. Smits (The Netherlands), F. Van Lanschot, T. Bakker Schut, J. Hardillo, H. Mast, I. Ten Hove, E. Wolvius, G. Puppels, R. Baatenburg de Jong, S. Koljenovic The role of T-N tract in advanced stage tongue cancer M. Tagliabue (Italy), S. Gandini, V. Navach, F. Maffini, R. Bruschini, G. Giugliano, M. Tommasino, L. Calabrese, M. Ansarin Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic HNSCC P. Bonomo (Italy), I. Desideri, C. Becherini, M. Loi, E. Orlandi, N.A. Iacovelli, V. Salvestrini, M. Mariotti, L. Visani, L. Livi Managing recurrent/metastatic Head and Neck cancer in the real-world: Paclitaxel plus Cetuximab I. Leão (Portugal), R. Neto, J. Marinho, E. Neto, E. Dias, A. Joaquim HDR Interstitial brachytherapy in Recurrent Head and Neck cancer: An effective Salvage option V. Pareek (India), R. Bhalavat, M. Chandra, L. Nellore, K. George, D. Borade, K. Kalariya, Z. Moosa, N. Reddy, A. Srivastava, A. Kapoor, D. Kawale, P. Bauskar

PO-095

PO-096

PO-097

PO-098

PO-099

PO-100

POSTERS | PROGRAMME & EXHIBITION GUIDE

34

POSTER Biology, HPV and molecular targeting

HPV, tobacco smoking and specific mutations and amplifications in oropharyngeal cancer J. Lilja-Fischer (Denmark), B. Ulhøi, M. Stougaard, P. Lassen, T. Steniche, J. Alsner, J. Overgaard Amplification of genes at 11q13 in relation to HPV status in Head and Neck squamous cell carcinomas J.P. Rodrigo (Spain), F. Hermida-Prado, S. Tirados Menendez, R. Granda-Díaz, L. Alonso Durán, X. Leon, L. Alemany, M. Mena, N. Del Rio Ibisate, A. Astudillo, J.M. García-Pedrero Competing mortality in oropharyngeal carcinoma according to HPV status J.M. Costa González (Spain), J. Lop, J. García, M. López, M. Taberna, M. Mena, L. Alemany, A. Sumarroca, M. Quer, X. León Predictors for an improved survival in surgically treated patients - Risk stratification in OPSCC N. Würdemann (Germany), S. Wagner, C. Wittekindt, S.J. Sharma, M. Reuschenbach, E. Prigge, M. Von Knebel-Doeberitz, S. Gattenlöhner, E. Burkhardt, J. Pons-Kühnemann, J.P. Klußmann UICC TNM 8th Edition Staging in Oropharyngeal Cancer: Validation in a UK Single Centre Cohort Abstract withdrawn Intratumor heterogeneity of PD-L1 expression in Head and Neck squamous cell carcinoma J. Rasmussen (Denmark), G. Lelkaitis, K. Håkansson, I.R. Vogelius, H.H. Johannesen, B.M. Fischer, L. Specht, C.A. Kristensen, C.V. Buchwald, I. Wessel, J. Friborg CAFs secrete factors that sustain cancer stem properties in Head and Neck squamous carcinoma cells J.P. Rodrigo (Spain), S. Alvarez-Teijeiro, C. García-Inclán, M.A. Villaronga, P. Casado, R. Granda-Díaz, F. Calvo, N. Del Rio Ibisate, A. Gandarillas, P. Cutillas, F. Moris, J.M. García Pedrero

PO-101

PO-102

PO-103

PO-104

PO-105

PO-106

PO-107

PROGRAMME & EXHIBITION GUIDE | POSTERS

35

Clinical relevance of Cortactin and Focal Adhesion Kinase as predictors of laryngeal cancer risk J.P. Rodrigo (Spain), R. Granda Diaz, M.A. Villaronga, F. Hermida Prado, S. Tirados Menendez, M. Quer, I. Vilaseca, M. Sánchez Canteli, V. Sanz-Moreno, A. Astudillo, J.M. García Pedrero Influence of HPV in the recruitment of macrophages in HNSCC I. Seminerio (Belgium), L. De Marrez, J. Laigle, A. Kabagire, F. Journe, S. Saussez Potential proteomic profiling of local relapse in nasopharyngeal carcinoma from a non-endemic region E. Netto (Portugal), H. Santos, L. Carvalho, J.L. Capelo-Martínez, M. Roldão The use of a serum proteomic signature to improve HPV classification of OPSCC: A pilot study A. Dickinson (Finland), M. Saraswat, S. Joenväärä, T. Carpén, T. Tohmola, P. Mattila, C. Haglund, J. Haagström, A. Mäkitie, S. Silén The role of microbiota in predicting oral mucositis in Head and Neck cancer patients treated with IMRT E. Orlandi (Italy), N.A. Iacovelli, L. De Cecco, T. Rancati, A. Cavallo, L. Ferella, E. Mancinelli, M.S. Serafini, A. Devecchi, T. Giandini, A. Cicchetti, P. Bossi, S. Alfieri, L. Locati, L. Licitra, C. Fallai, R. Valdagni

PO-108

PO-109

PO-110

PO-111

PO-112

POSTERS | PROGRAMME & EXHIBITION GUIDE

36

POSTER Imaging and radiomics

DWMRI as biomarker of response during RT for intermed/high risk SCC oropharynx: a feasibility study C. Paterson (United Kingdom), I. McCrea, L. Hay, S. Allwood-Speris, L. Devlin, M. Sankaralingam, P. McLoone, C. Wilson, D. Grose, A. James, C. Lamb, M. Rizwanullah, S. Schipani, N. Ioanna, M. Thomson, M. McJury, J. Foster, A. Duffton Variability in target volume delineation in Head and Neck cancer: Results of a national study J. Van der Veen (Belgium), A. Gulyban, S. Nuyts Radiomics-based prediction of response to induction chemotherapy in sinonasal cancer P. Bossi (Italy), G. Calareso, C. Resteghini, S. Sdao, E. Montin, V. Corino, L. Mainardi, L. Licitra Diagnostic and prognostic impact of 18F-FDG PET/CT imaging in patients with nasopharyngeal carcinoma J. Dura Esteve (Spain), M. Alarza Cano, A. Ruiz Alonso, L. Iglesias Docampo, A.C. Hernández Martínez, A. Mera Errasti, I. Alda Bravo, M. Fasano Moore, J.F. Pérez-Regadera Gómez Can we reduce the posterior margins during irradiation of nasopharyngeal cancer? L. Farhat, N. Fourati (Tunisia), W. Mnekka, Z. Fessi, T. Sahnoun, W. Siala, J. Daoud PET/CT versus standard imaging for prediction of survival in patients with recurrent HNSCC M. Rohde (Denmark), J. Johansen, J.A. Sørensen, A.L. Lerberg, J.T. Asmussen, P.F. Høilund-Carlsen, C. Godballe Pattern of failure in Head and Neck cancer after definitive RT-CT based on pre-treatment 18F-FDG PET/CT uptake L. Deantonio (Italy), L. Vigna, V. Amisano, L. Masini, P. Aluffi, G.M. Sacchetti, G. Loi, M. Krengli

PO-113

PO-114

PO-115

PO-116

PO-117

PO-118

PO-119

PROGRAMME & EXHIBITION GUIDE | POSTERS

37

Up-front F18-FDG PET/CT in suspected salivary gland carcinoma M. Westergaard-Nielsen (Denmark) Use of radiomics in the recurrence patterns after IMRT for Head and Neck cancer: a preliminary study S. Li (China), Z. Hou, K. Wang, J. Yang, W. Ren, S. Gao, F. Meng, P. Wu, B. Liu, J. Liu, J. Yan CT /PET based dosiomics and radiomics model predicts local control of nasopharyngeal carcinoma G. Fanetti (Italy), M. Avanzo, G. Pirrone, C. Avigo, J. Stancanello, A. De Paoli, E. Palazzari, A. Drigo, C. Gobitti, E. Vaccher, T. Baresic, C. Bampo, E. Borsatti, G. Sartor, G. Franchin Early changes in multiparametric imaging parameters during radiotherapy of squamous carcinoma K. Zborayova (Sweden), H. Antti, L. Blomqvist, L. Flygare, M. Gebre-Medhin, J. Jonsson, K. Söderkvist, B. Zackrisson Three-dimensional radiation dose of osteoradionecrosis in oropharyngeal cancer receiving IMRT A.S.R. Mohamed (USA), K. Al Feghali, S. Ng, H. Elhalawani, K. Hutcheson, M. Chambers, J. Phan, J. Kraeima, H. Glas, M. Witjes, G.B. Gunn, A. Garden, D. Rosenthal, S. Frank, W. Morrison, F. Clifton, S. Lai Visibility study for GTVp delineation for Head and Neck following recent consensus guidelines S. Whittam (United Kingdom), B. Al-Qaisieh, R. Prestwich, K. Cardale, S. Ramasamy, P. Murray, K. Dyker, M. Sen Predictors of dose differences to swallowing OARs in patients undergoing radiotherapy for HNC D. Noble (United Kingdom), K. Harrison, M. Wilson, A. Hoole, S. Thomas, N. Burnet, R. Jena How to optimize prophylactic lymph node irradiation in nasopharyngeal carcinoma? N. Fourati (Tunisia), Z. Fessi, W. Mnejja, W. Siala, J. Daoud Our experience of using telestration in Head and Neck cancer patients R. Jones (United Kingdom), S. Bodnaresu, L. Pope

PO-120

PO-121

PO-122

PO-123

PO-124

PO-125

PO-126

PO-127

PO-128

POSTERS | PROGRAMME & EXHIBITION GUIDE

38

Set-up errors in Head and Neck cancer patients undergoing IGRT. Relationship to BMI and weight loss A. Allajbej (Italy), F. Patani, M. Trignani, A. Di Pilla, P. Bagalà, A. Vinciguerra, A. Augurio, G. Caravaggio, M.D. Falco, D. Genovesi Evaluation of a ‘dose-of-the-day’ workflow for Head and Neck cancer patients E. Berthelet (Canada), L. Nica, S. Hamilton, E. Tran, J. Wu, M. Welsh, N. McVicar Prognostic radiological features in early stage HPV positive oropharyngeal cancer M. Echevarria (USA), A. Trotti, L. Harrison, J. Caudell

PO-129

PO-130

PO-131

PROGRAMME & EXHIBITION GUIDE | POSTERS

39

POSTER Supportive care, quality of life, rehabilitation

HNC patients´ experience of symptoms during radiotherapy compared to Patient-Reported Outcome tools C. Hollaender-Mieritz (Denmark), J. Johansen, C. Johansen, I.R. Vogelius, C.A. Kristensen, H. Pappot Prospective assessment of dysgeusia during radiotherapy for Head and Neck cancer S. Martini (Italy), G.C. Iorio, E. Olimpio, F. Arcadipane, P. Franco, U. Ricardi Clinical and dosimetric predictors of oral mucositis in the treatment of Head and Neck cancer F. Arcadipane (Italy), E. Olimpio, R. Ragona, S. Martini, G.C. Iorio, E. Gallio, J. Di Muzio, P. Franco, U. Ricardi Laryngeal Dose correlation with Voice changes in Head and Neck cancer patients treated by VMAT J. Mathew (India), A. Mukherji, S. Saxena, P. Vedasoundaram, A. Menon, N. Vijayaraghavan Head and Neck symptoms evolution during chemo-radiotherapy: A prospective assessment N. Fourati (Tunisia), Z. Fessi, W. Mnejja, O. Nouri, W. Ben Kridis, A. Khanfir, W. Siala, J. Daoud Psycho-Social Issues in Ca H & N survivors with respect to physical wellbeing- A retrospective study A. Tiwari (India) Prognostic value of tailored nutritional support in Head and Neck cancer patients undergoing treatments L. Tondulli (Italy) , I. Trestini, L. Carbognin, I. Sperduti, C. Bonaiuto, S. Pilotto, G. Tortora, M. Milella, E. Bria Second Primary Cancer in Salivary gland cancer: A Nationwide Population-based Study J. Heo (Korea Republic of), Y. Oh, O.K. Noh, M. Chun, C. Kim, Y.S. Shin

PO-132

PO-133

PO-134

PO-135

PO-136

PO-137

PO-138

PO-139

POSTERS | PROGRAMME & EXHIBITION GUIDE

40

Psychiatric comorbidities among tongue cancer in South Korea: A nationwide population-based study J. Heo (Korea Republic of), Y. Oh, O.K. Noh, M. Chun, C. Kim, Y.S. Shin The Effects of Biobran on Head and Neck Cancer Patients Undergoing Radiotherapy: A Double Blind RCT J.A. Flores (Philippines), D.F. Tan, M.A.G. Reyna, M.J. Calaguas, J. Canedo, E.M. Chiong, C. Yu, L. Rodriguez, R. Marquez Swallowing tests and aspiration pneumonia in advanced Head and Neck cancer : preliminary data G. Lazzari (Italy), M. De Cillis, A. Terlizzi, G. Silvano Long-term Functional Outcome after Laryngeal Cancer Treatment R. Giger (Switzerland), L. Anschuetz, M. Shelan, M. Dematté, O. Elicin Follow-up of the Head and Neck cancer patients after therapy - are we doing right things? H. Irjala (Finland), E. Kytö, E. Haapio, H. Minn Voice outcome in patients with early glottic cancer following radiotherapy versus laser microsurgery A. Allajbej (Italy), F. Patani, S. Di Biase, D. Fasciolo, C. Di Carlo, C. Rosa, L. Gasparini, M. Di Francesco, G. Falcone, G. Quaternato, A. Croce, A. Di Pilla, M. Trignani, D. Genovesi Radiation therapy of sinonasal carcinoma: A multidimensional study of sequelae and quality of life M.B. Sharma (Denmark), K. Jensen, S.F. Urbak, M. Funding, S.S. Korreman, C. Grau Functional outcome of postoperative IMRT after laryngeal conservative surgery S. Volpe (Italy), A. Bagicalupo, D. Alterio, L. Belgioia, A. Ferrari, V. Zurlo, V. Santomauro, G. Marvaso, M. Montesano, M. Augugliaro, I. Turturici, S. Vigorito, R. Corvò, B.A. Jereczek-Fossa Management of bio-radiation dermatitis in HNSCC: emphasizing the role of calcium alginate dressings P. Bonomo (Italy), I. Desideri, M. Loi, L.P. Ciccone, M. Lo Russo, C. Becherini, L. Visani, V. Salvestrini, M. Mariotti, N. Pimpinelli, L. Livi

PO-140

PO-141

PO-142

PO-143

PO-144

PO-145

PO-146

PO-147

PO-148

PROGRAMME & EXHIBITION GUIDE | POSTERS

41